117 related articles for article (PubMed ID: 38513324)
21. A new porphyrin as selective substrate-based inhibitor of breast cancer resistance protein (BCRP/ABCG2).
Zattoni IF; Kronenberger T; Kita DH; Guanaes LD; Guimarães MM; de Oliveira Prado L; Ziasch M; Vesga LC; Gomes de Moraes Rego F; Picheth G; Gonçalves MB; Noseda MD; Ducatti DRB; Poso A; Robey RW; Ambudkar SV; Moure VR; Gonçalves AG; Valdameri G
Chem Biol Interact; 2022 Jan; 351():109718. PubMed ID: 34717915
[TBL] [Abstract][Full Text] [Related]
22. Semi-Synthesis and In Vitro Anti-Cancer Evaluation of Magnolol Derivatives.
Sun XL; Zhu ML; Dai YQ; Li HM; Li BH; Ma H; Zhang CH; Wu CZ
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299577
[TBL] [Abstract][Full Text] [Related]
23. Structures of ABCG2 under turnover conditions reveal a key step in the drug transport mechanism.
Yu Q; Ni D; Kowal J; Manolaridis I; Jackson SM; Stahlberg H; Locher KP
Nat Commun; 2021 Jul; 12(1):4376. PubMed ID: 34282134
[TBL] [Abstract][Full Text] [Related]
24. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties.
Xiong G; Wu Z; Yi J; Fu L; Yang Z; Hsieh C; Yin M; Zeng X; Wu C; Lu A; Chen X; Hou T; Cao D
Nucleic Acids Res; 2021 Jul; 49(W1):W5-W14. PubMed ID: 33893803
[TBL] [Abstract][Full Text] [Related]
25. Tetrahydroquinoline/4,5-Dihydroisoxazole Molecular Hybrids as Inhibitors of Breast Cancer Resistance Protein (BCRP/ABCG2).
Vesga LC; Kronenberger T; Tonduru AK; Kita DH; Zattoni IF; Bernal CC; Bohórquez ARR; Mendez-Sánchez SC; Ambudkar SV; Valdameri G; Poso A
ChemMedChem; 2021 Sep; 16(17):2686-2694. PubMed ID: 33844464
[TBL] [Abstract][Full Text] [Related]
26. Mechanistic basis of breast cancer resistance protein inhibition by new indeno[1,2-b]indoles.
Kita DH; Guragossian N; Zattoni IF; Moure VR; Rego FGM; Lusvarghi S; Moulenat T; Belhani B; Picheth G; Bouacida S; Bouaziz Z; Marminon C; Berredjem M; Jose J; Gonçalves MB; Ambudkar SV; Valdameri G; Le Borgne M
Sci Rep; 2021 Jan; 11(1):1788. PubMed ID: 33469044
[TBL] [Abstract][Full Text] [Related]
27. Uncompetitive nanomolar dimeric indenoindole inhibitors of the human breast cancer resistance pump ABCG2.
Guragossian N; Belhani B; Moreno A; Nunes MT; Gonzalez-Lobato L; Marminon C; Berthier L; Rocio Andrade Pires AD; Özvegy-Laczka C; Sarkadi B; Terreux R; Bouaziz Z; Berredjem M; Jose J; Di Pietro A; Falson P; Le Borgne M
Eur J Med Chem; 2021 Feb; 211():113017. PubMed ID: 33223263
[TBL] [Abstract][Full Text] [Related]
28. The transport pathway in the ABCG2 protein and its regulation revealed by molecular dynamics simulations.
Nagy T; Tóth Á; Telbisz Á; Sarkadi B; Tordai H; Tordai A; Hegedűs T
Cell Mol Life Sci; 2021 Mar; 78(5):2329-2339. PubMed ID: 32979053
[TBL] [Abstract][Full Text] [Related]
29. Rociletinib (CO-1686) enhanced the efficacy of chemotherapeutic agents in ABCG2-overexpressing cancer cells
Zeng F; Wang F; Zheng Z; Chen Z; Wah To KK; Zhang H; Han Q; Fu L
Acta Pharm Sin B; 2020 May; 10(5):799-811. PubMed ID: 32528828
[TBL] [Abstract][Full Text] [Related]
30. Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells
Yang Y; Ji N; Teng QX; Cai CY; Wang JQ; Wu ZX; Lei ZN; Lusvarghi S; Ambudkar SV; Chen ZS
Front Oncol; 2020; 10():700. PubMed ID: 32477943
[TBL] [Abstract][Full Text] [Related]
31. ABCG2 transports anticancer drugs via a closed-to-open switch.
Orlando BJ; Liao M
Nat Commun; 2020 May; 11(1):2264. PubMed ID: 32385283
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of Bisphenol Neolignans Inspired by Honokiol as Antiproliferative Agents.
Cardullo N; Barresi V; Muccilli V; Spampinato G; D'Amico M; Condorelli DF; Tringali C
Molecules; 2020 Feb; 25(3):. PubMed ID: 32046220
[TBL] [Abstract][Full Text] [Related]
33. ATP-dependent thermostabilization of human P-glycoprotein (ABCB1) is blocked by modulators.
Lusvarghi S; Ambudkar SV
Biochem J; 2019 Dec; 476(24):3737-3750. PubMed ID: 31774117
[TBL] [Abstract][Full Text] [Related]
34. Magnolol Suppresses TGF-β-Induced Epithelial-to-Mesenchymal Transition in Human Colorectal Cancer Cells.
Chei S; Oh HJ; Song JH; Seo YJ; Lee K; Lee BY
Front Oncol; 2019; 9():752. PubMed ID: 31632899
[TBL] [Abstract][Full Text] [Related]
35. Multi-target ABC transporter modulators: what next and where to go?
Stefan SM
Future Med Chem; 2019 Sep; 11(18):2353-2358. PubMed ID: 31516029
[No Abstract] [Full Text] [Related]
36. Magnolol attenuates the inflammation and enhances phagocytosis through the activation of MAPK, NF-κB signal pathways in vitro and in vivo.
Chen H; Fu W; Chen H; You S; Liu X; Yang Y; Wei Y; Huang J; Rui W
Mol Immunol; 2019 Jan; 105():96-106. PubMed ID: 30500626
[TBL] [Abstract][Full Text] [Related]
37. Specific and reliable detection of Myosin 1C isoform A by RTqPCR in prostate cancer cells.
Saidova AA; Potashnikova DM; Tvorogova AV; Maly IV; Hofmann WA; Vorobjev IA
PeerJ; 2018; 6():e5970. PubMed ID: 30498638
[TBL] [Abstract][Full Text] [Related]
38. Ulixertinib (BVD-523) antagonizes ABCB1- and ABCG2-mediated chemotherapeutic drug resistance.
Ji N; Yang Y; Lei ZN; Cai CY; Wang JQ; Gupta P; Xian X; Yang DH; Kong D; Chen ZS
Biochem Pharmacol; 2018 Dec; 158():274-285. PubMed ID: 30431011
[TBL] [Abstract][Full Text] [Related]
39. Magnolol: A Neolignan from the Magnolia Family for the Prevention and Treatment of Cancer.
Ranaware AM; Banik K; Deshpande V; Padmavathi G; Roy NK; Sethi G; Fan L; Kumar AP; Kunnumakkara AB
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30103472
[TBL] [Abstract][Full Text] [Related]
40. Identification by Inverse Virtual Screening of magnolol-based scaffold as new tankyrase-2 inhibitors.
Di Micco S; Pulvirenti L; Bruno I; Terracciano S; Russo A; Vaccaro MC; Ruggiero D; Muccilli V; Cardullo N; Tringali C; Riccio R; Bifulco G
Bioorg Med Chem; 2018 Aug; 26(14):3953-3957. PubMed ID: 29934219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
